Pharmafile Logo
Pharmafocus logo
Advanced Search

prostate

Showing 15 posts of 18 posts found.

Jevtana image

Sanofi prostate cancer drug to remain on CDF

May 26, 2015
Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate

Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …

News
Caner image

More cancer patients surviving for longer

October 31, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

News

FDA approves new indication for Xtandi

September 11, 2014
Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate

The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …

News
cancer image

Top four cancer killer rates ‘fall by a third’

August 18, 2014
Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

News
Zytiga image

Charities ‘disappointed’ in NICE and Janssen

August 15, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate

The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …

News
John Johnson image

Dendreon chief resigns from struggling firm

June 10, 2014
Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate

Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …

News
Zytiga image

NICE: no early Zytiga use

May 14, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …

News

NICE recommends Xtandi

May 9, 2014
Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate

NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

News
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
sir michael parkinson image

Sir Michael Parkinson criticises NICE

February 4, 2014
Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate

TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …

News
Roche image

Roche signs $17 million immatics deal

November 15, 2013
Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate

Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …

News
Go dad run image

Lilly UK sponsors ‘Go Dad Run’ charity

June 6, 2013
Medical Communications go dad run, lilly, prostate

Lilly is sponsoring Olympic hurdler Colin Jackson’s ‘Go Dad Run’, a new 5k run for men to raise awareness of …

News

Patients ‘shut out’ of drug price talks

November 13, 2012
Sales and Marketing Cancer, NHS, NICE, VBP, prostate

Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …

News
AZ app image

AstraZeneca launches prostate cancer app

August 7, 2012
Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

News
Zytiga image

Janssen looks to broaden Zytiga licence

June 18, 2012
Sales and Marketing Cancer, Janssen, NICE, Provenge, Zytiga, prostate

Janssen is looking to broaden the licence for its prostate cancer pill Zytiga. Zytiga currently has a US and European …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024